Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

195.20p
   
  • Change Today:
    -6.80p
  • 52 Week High: 470.00
  • 52 Week Low: 166.80
  • Currency: UK Pounds
  • Shares Issued: 100.00m
  • Volume: 148,843
  • Market Cap: £195.20m
  • RiskGrade: 125

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
48.31% below the market average48.31% below the market average48.31% below the market average48.31% below the market average48.31% below the market average
25.71% below the sector average25.71% below the sector average25.71% below the sector average25.71% below the sector average25.71% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
19.49% below the market average19.49% below the market average19.49% below the market average19.49% below the market average19.49% below the market average
65.52% below the sector average65.52% below the sector average65.52% below the sector average65.52% below the sector average65.52% below the sector average
Price Book Ratio
27.60% above the market average27.60% above the market average27.60% above the market average27.60% above the market average27.60% above the market average
59.18% above the sector average59.18% above the sector average59.18% above the sector average59.18% above the sector average59.18% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
63.35% above the market average63.35% above the market average63.35% above the market average63.35% above the market average63.35% above the market average
57.89% above the sector average57.89% above the sector average57.89% above the sector average57.89% above the sector average57.89% above the sector average
Price Chg 3m
32.86% above the market average32.86% above the market average32.86% above the market average32.86% above the market average32.86% above the market average
57.89% above the sector average57.89% above the sector average57.89% above the sector average57.89% above the sector average57.89% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
21.16% above the market average21.16% above the market average21.16% above the market average21.16% above the market average21.16% above the market average
47.17% above the sector average47.17% above the sector average47.17% above the sector average47.17% above the sector average47.17% above the sector average
Momentum 20
49.80% above the market average49.80% above the market average49.80% above the market average49.80% above the market average49.80% above the market average
73.58% above the sector average73.58% above the sector average73.58% above the sector average73.58% above the sector average73.58% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
56.09% below the market average56.09% below the market average56.09% below the market average56.09% below the market average56.09% below the market average
16.67% above the sector average16.67% above the sector average16.67% above the sector average16.67% above the sector average16.67% above the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
94.88% below the market average94.88% below the market average94.88% below the market average94.88% below the market average94.88% below the market average
92.59% below the sector average92.59% below the sector average92.59% below the sector average92.59% below the sector average92.59% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
30.85% above the market average30.85% above the market average30.85% above the market average30.85% above the market average30.85% above the market average
44.44% above the sector average44.44% above the sector average44.44% above the sector average44.44% above the sector average44.44% above the sector average
Operating Profit Loss
90% below the market average90% below the market average90% below the market average90% below the market average90% below the market average
77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
56.47% above the market average56.47% above the market average56.47% above the market average56.47% above the market average56.47% above the market average
65.38% above the sector average65.38% above the sector average65.38% above the sector average65.38% above the sector average65.38% above the sector average
Cash
72.73% above the market average72.73% above the market average72.73% above the market average72.73% above the market average72.73% above the market average
74.07% above the sector average74.07% above the sector average74.07% above the sector average74.07% above the sector average74.07% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y
61.85% above the market average61.85% above the market average61.85% above the market average61.85% above the market average61.85% above the market average
54.84% above the sector average54.84% above the sector average54.84% above the sector average54.84% above the sector average54.84% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
87.26% below the market average87.26% below the market average87.26% below the market average87.26% below the market average87.26% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Brokers Percent Neutral
83.56% above the market average83.56% above the market average83.56% above the market average83.56% above the market average83.56% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 195.20p
Change Today -6.80p
% Change -3.37 %
52 Week High 470.00
52 Week Low 166.80
Volume 148,843
Shares Issued 100.00m
Market Cap £195.20m
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
43.78% above the market average43.78% above the market average43.78% above the market average43.78% above the market average43.78% above the market average
81.13% above the sector average81.13% above the sector average81.13% above the sector average81.13% above the sector average81.13% above the sector average
Price Trend
80.52% below the market average80.52% below the market average80.52% below the market average80.52% below the market average80.52% below the market average
19.3% below the sector average19.3% below the sector average19.3% below the sector average19.3% below the sector average19.3% below the sector average
Income Not Available
Growth
4.91% above the market average4.91% above the market average4.91% above the market average4.91% above the market average4.91% above the market average
51.35% above the sector average51.35% above the sector average51.35% above the sector average51.35% above the sector average51.35% above the sector average

What The Brokers Say

Strong Buy 1
Buy 2
Neutral 7
Sell 0
Strong Sell 0
Total 10
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 16-Apr-2024

Time Volume / Share Price
16:35 29,444 @ 195.20p
16:35 217 @ 195.20p
16:35 340 @ 195.20p
16:35 311 @ 195.20p
16:35 356 @ 195.20p

OXB Key Personnel

CFO Stuart Paynter
CEO Frank Mathias

Top of Page